Capvizr
THE DEAL, AT A GLANCE

GeoVax

From the announcement
01What it doesGeoVax is a Digital Health company focused on use the funds for clinical trial expenses and working capital.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by the private placement for clinical trial expenses, working capitalFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedGeoVax raised $2.7M Unknown, announced 2026-05-19From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersGeoVax's $2.7M financing is a small-cap clinical funding event within an active Healthcare & Life Sciences tape, with the round positioned at the 5th percentile despite…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

GeoVax · Financing Record

Explore source-linked visual explanations for GeoVax. Unsupported claims are withheld while source review continues.

Record 4089 · Recorded date: 2026-05-19

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime